SS Innovations International (SSII) Competitors

$4.13 +0.05 (+1.23%)

As of 02:51 PM Eastern

SSII vs. SLNO, LMAT, WRBY, AXGN, and ESTA

Should you buy SS Innovations International stock or one of its competitors? MarketBeat compares SS Innovations International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SS Innovations International include Soleno Therapeutics (SLNO), LeMaitre Vascular (LMAT), Warby Parker (WRBY), AxoGen (AXGN), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

How does SS Innovations International compare to Soleno Therapeutics?

SS Innovations International (NASDAQ:SSII) and Soleno Therapeutics (NASDAQ:SLNO) are both medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

97.4% of Soleno Therapeutics shares are owned by institutional investors. 6.4% of Soleno Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Soleno Therapeutics has a net margin of 33.70% compared to SS Innovations International's net margin of -28.54%. Soleno Therapeutics' return on equity of 22.85% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-28.54%	-30.23%	-17.50%
Soleno Therapeutics	33.70%	22.85%	18.25%

Soleno Therapeutics has a consensus price target of $76.67, indicating a potential upside of 44.83%. Given Soleno Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Soleno Therapeutics is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Soleno Therapeutics	1 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.15

Soleno Therapeutics has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	19.45	-$12.13M	-$0.06	N/A
Soleno Therapeutics	$190.40M	14.49	$20.89M	$0.23	230.15

In the previous week, Soleno Therapeutics had 2 more articles in the media than SS Innovations International. MarketBeat recorded 7 mentions for Soleno Therapeutics and 5 mentions for SS Innovations International. Soleno Therapeutics' average media sentiment score of 0.59 beat SS Innovations International's score of 0.37 indicating that Soleno Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Soleno Therapeutics	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Soleno Therapeutics beats SS Innovations International on 14 of the 15 factors compared between the two stocks.

How does SS Innovations International compare to LeMaitre Vascular?

LeMaitre Vascular (NASDAQ:LMAT) and SS Innovations International (NASDAQ:SSII) are both medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

LeMaitre Vascular has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	9.01	$57.73M	$2.71	36.30
SS Innovations International	$42.49M	19.45	-$12.13M	-$0.06	N/A

LeMaitre Vascular has a net margin of 24.35% compared to SS Innovations International's net margin of -28.54%. LeMaitre Vascular's return on equity of 15.36% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	24.35%	15.36%	9.78%
SS Innovations International	-28.54%	-30.23%	-17.50%

In the previous week, LeMaitre Vascular had 33 more articles in the media than SS Innovations International. MarketBeat recorded 38 mentions for LeMaitre Vascular and 5 mentions for SS Innovations International. LeMaitre Vascular's average media sentiment score of 0.49 beat SS Innovations International's score of 0.37 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	10 Very Positive mention(s)	6 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
SS Innovations International	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

84.6% of LeMaitre Vascular shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

LeMaitre Vascular presently has a consensus target price of $112.60, indicating a potential upside of 14.45%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, research analysts plainly believe LeMaitre Vascular is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.75
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

LeMaitre Vascular beats SS Innovations International on 15 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to Warby Parker?

Warby Parker (NYSE:WRBY) and SS Innovations International (NASDAQ:SSII) are both medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Warby Parker currently has a consensus price target of $29.00, suggesting a potential upside of 5.63%. Given Warby Parker's stronger consensus rating and higher probable upside, equities research analysts clearly believe Warby Parker is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Warby Parker	1 Sell rating(s)	5 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.56
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Warby Parker had 18 more articles in the media than SS Innovations International. MarketBeat recorded 23 mentions for Warby Parker and 5 mentions for SS Innovations International. Warby Parker's average media sentiment score of 0.52 beat SS Innovations International's score of 0.37 indicating that Warby Parker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Warby Parker	7 Very Positive mention(s)	2 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
SS Innovations International	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Warby Parker has a net margin of 0.15% compared to SS Innovations International's net margin of -28.54%. Warby Parker's return on equity of 2.32% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Warby Parker	0.15%	2.32%	1.19%
SS Innovations International	-28.54%	-30.23%	-17.50%

93.2% of Warby Parker shares are owned by institutional investors. 18.2% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Warby Parker has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Warby Parker	$890.57M	3.30	$1.64M	$0.02	1,372.75
SS Innovations International	$42.49M	19.45	-$12.13M	-$0.06	N/A

Summary

Warby Parker beats SS Innovations International on 14 of the 15 factors compared between the two stocks.

How does SS Innovations International compare to AxoGen?

AxoGen (NASDAQ:AXGN) and SS Innovations International (NASDAQ:SSII) are both medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

AxoGen currently has a consensus target price of $46.50, indicating a potential upside of 13.12%. Given AxoGen's stronger consensus rating and higher possible upside, equities analysts clearly believe AxoGen is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	2 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.64
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

SS Innovations International has lower revenue, but higher earnings than AxoGen. SS Innovations International is trading at a lower price-to-earnings ratio than AxoGen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$225.21M	9.71	-$15.70M	-$0.64	N/A
SS Innovations International	$42.49M	19.45	-$12.13M	-$0.06	N/A

80.3% of AxoGen shares are owned by institutional investors. 2.4% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

AxoGen has a net margin of -13.21% compared to SS Innovations International's net margin of -28.54%. AxoGen's return on equity of -9.63% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-13.21%	-9.63%	-6.26%
SS Innovations International	-28.54%	-30.23%	-17.50%

In the previous week, AxoGen had 3 more articles in the media than SS Innovations International. MarketBeat recorded 8 mentions for AxoGen and 5 mentions for SS Innovations International. AxoGen's average media sentiment score of 0.67 beat SS Innovations International's score of 0.37 indicating that AxoGen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SS Innovations International	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

AxoGen beats SS Innovations International on 12 of the 15 factors compared between the two stocks.

How does SS Innovations International compare to Establishment Labs?

SS Innovations International (NASDAQ:SSII) and Establishment Labs (NASDAQ:ESTA) are both medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

In the previous week, Establishment Labs had 10 more articles in the media than SS Innovations International. MarketBeat recorded 15 mentions for Establishment Labs and 5 mentions for SS Innovations International. Establishment Labs' average media sentiment score of 0.44 beat SS Innovations International's score of 0.37 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Establishment Labs	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Establishment Labs has a consensus target price of $87.14, suggesting a potential upside of 25.67%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts clearly believe Establishment Labs is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63

SS Innovations International has higher earnings, but lower revenue than Establishment Labs. SS Innovations International is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	19.45	-$12.13M	-$0.06	N/A
Establishment Labs	$211.08M	9.65	-$51.06M	-$1.49	N/A

72.9% of Establishment Labs shares are held by institutional investors. 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Establishment Labs has a net margin of -19.05% compared to SS Innovations International's net margin of -28.54%. SS Innovations International's return on equity of -30.23% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-28.54%	-30.23%	-17.50%
Establishment Labs	-19.05%	-202.78%	-12.39%

Summary

Establishment Labs beats SS Innovations International on 11 of the 15 factors compared between the two stocks.

Get SS Innovations International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SSII vs. The Competition

Export

Metric	SS Innovations International	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$826.54M	$3.85B	$6.36B	$12.10B
Dividend Yield	N/A	1.99%	3.04%	5.23%
P/E Ratio	-68.83	52.98	30.77	25.41
Price / Sales	19.45	50.34	441.00	75.53
Price / Cash	N/A	39.02	22.61	36.29
Price / Book	20.65	5.70	6.12	6.65
Net Income	-$12.13M	$31.15M	$200.03M	$333.40M
7 Day Performance	5.90%	-1.09%	-1.27%	-0.58%
1 Month Performance	-3.95%	8.87%	4.99%	7.66%
1 Year Performance	-59.31%	35.79%	40.07%	35.36%

SS Innovations International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SSII SS Innovations International	1.3746 of 5 stars	$4.13 +1.2%	N/A	-59.6%	$826.54M	$42.49M	N/A	4	Short Interest Decrease
SLNO Soleno Therapeutics	3.4961 of 5 stars	$52.87 +0.1%	$76.67 +45.0%	-31.0%	$2.73B	$190.41M	229.88	30
LMAT LeMaitre Vascular	4.5066 of 5 stars	$112.04 +2.1%	$105.80 -5.6%	+26.7%	$2.51B	$249.60M	44.64	490	Trending News Earnings Report Insider Trade
WRBY Warby Parker	3.0759 of 5 stars	$23.13 +4.6%	$28.09 +21.4%	+81.7%	$2.37B	$871.91M	1,157.18	4,036	Earnings Report
AXGN AxoGen	3.3088 of 5 stars	$43.28 +0.2%	$46.50 +7.4%	+259.1%	$2.24B	$238.11M	N/A	450

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SSII) was last updated on 5/12/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SS Innovations International (SSII) Competitors

SSII vs. SLNO, LMAT, WRBY, AXGN, and ESTA

How does SS Innovations International compare to Soleno Therapeutics?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Summary

How does SS Innovations International compare to Warby Parker?

Summary

How does SS Innovations International compare to AxoGen?

Summary

How does SS Innovations International compare to Establishment Labs?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SS Innovations International (SSII) Competitors

SSII vs. SLNO, LMAT, WRBY, AXGN, and ESTA

How does SS Innovations International compare to Soleno Therapeutics?

Do institutionals and insiders believe in SSII or SLNO?

Is SSII or SLNO more profitable?

Do analysts prefer SSII or SLNO?

Which has preferable earnings and valuation, SSII or SLNO?

Does the media favor SSII or SLNO?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Which has better valuation and earnings, LMAT or SSII?

Is LMAT or SSII more profitable?

Does the media favor LMAT or SSII?

Do institutionals and insiders believe in LMAT or SSII?

Do analysts prefer LMAT or SSII?

Summary

How does SS Innovations International compare to Warby Parker?

Do analysts recommend WRBY or SSII?

Does the media refer more to WRBY or SSII?

Is WRBY or SSII more profitable?

Do insiders & institutionals hold more shares of WRBY or SSII?

Which has better earnings & valuation, WRBY or SSII?

Summary

How does SS Innovations International compare to AxoGen?

Do analysts rate AXGN or SSII?

Which has higher valuation and earnings, AXGN or SSII?

Do insiders and institutionals have more ownership in AXGN or SSII?

Is AXGN or SSII more profitable?

Does the media favor AXGN or SSII?

Summary

How does SS Innovations International compare to Establishment Labs?

Does the media refer more to SSII or ESTA?

Do analysts prefer SSII or ESTA?

Which has better earnings & valuation, SSII or ESTA?

Do insiders & institutionals believe in SSII or ESTA?

Is SSII or ESTA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools